Your browser doesn't support javascript.
DOACs and "newer" hemophilia therapies in COVID-19: Reply.
Thachil, Jecko; Tang, Ning; Gando, Satoshi; Falanga, Anna; Cattaneo, Marco; Levi, Marcel; Clark, Cary; Iba, Toshiaki.
  • Thachil J; Department of Haematology, Manchester University Hospitals, Manchester, UK.
  • Tang N; Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Gando S; Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
  • Falanga A; Department of Transfusion Medicine and Hematology, Hospital Papa Giovanni, XXIII, Bergamo, Italy.
  • Cattaneo M; University of Milan Bicocca, Bergamo, Italy.
  • Levi M; ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
  • Clark C; Department of Medicine and Cardio-metabolic Programme-NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, UK.
  • Iba T; Director of Programs and Education, International Society on Thrombosis and Haemostasis, Carrboro, North Carolina.
J Thromb Haemost ; 18(7): 1795-1796, 2020 07.
Article in English | MEDLINE | ID: covidwho-1317981

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombosis / Coronavirus Infections / Pandemics / Hemophilia A Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14841

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Thrombosis / Coronavirus Infections / Pandemics / Hemophilia A Limits: Humans Language: English Journal: J Thromb Haemost Journal subject: Hematology Year: 2020 Document Type: Article Affiliation country: Jth.14841